Read the latest press releases for 4D pharma plc.

Click on a news title to read full details. For Regulatory News Service (RNS) announcements please click here.

Press release archive
Clinical
Clinical Update - Blautix Phase II study
8 Nov 2018, 12:13
4D pharma plc announces first patient enrolment in Blautix IBS Phase II study
Clinical
4D Announces Positive Data From Phase 1b Study of Thetanix in Paediatric Crohn's Disease Patients
24 Sep 2018, 15:56
4D pharma plc (AIM: DDDD), announces positive top-line results for its Phase 1b study of Thetanix in…
Publications
4D asthma publication
14 Aug 2018, 08:26
Data suggests that MRx0004 is a promising next-generation therapeutic for management of asthma
Publication - microbiota as HDAC inhibitors
30 Jul 2018, 08:32
30 July 2018 -- 4D pharma plc (AIM: DDDD), a pharmaceutical company leading the development of live…
4D Presents at IHMC 2018
27 Jun 2018, 08:35
4D pharma plc (AIM: DDDD), a pharmaceutical company leading the development of live biotherapeutics,…
MHRA and HPRA clear Blautix Phase II study
13 Jun 2018, 08:37
4D pharma plc (AIM: DDDD), a pharmaceutical company leading the development of live biotherapeutics,…
Clinical Collaboration Agreement
7 Jun 2018, 08:38
4D pharma plc (AIM: DDDD), a clinical stage biopharmaceutical company, pioneering the development of…
4D to present update on MRx0518 at upcoming meeting
4 Jun 2018, 11:45
4D pharma will present at the 2nd Annual Microbiome Discovery & Development Congress which takes…
4D Presents Phase Ib Clinical Data on Blautix
4 Jun 2018, 08:44
4D pharma plc (AIM: DDDD), a pharmaceutical company leading the development of live biotherapeutics,…
MRx0518 - Monotherapy trial approved
21 May 2018, 08:47
4D pharma plc (AIM: DDDD), a pharmaceutical company leading the development of live biotherapeutics,…
4D to participate in upcoming microbiome meeting
10 May 2018, 12:49
4D pharma will participate in the Global Engage Microbiome Futures Conference in New York on May…
Clinical Update - Blautix IND
8 May 2018, 08:49
4D pharma plc (AIM: DDDD), a pharmaceutical company leading the development of live biotherapeutics,…
Final Results
23 Apr 2018, 08:51
4D pharma plc (AIM: DDDD), a pharmaceutical company focusing on the development of live…
4D presents data on MRx0518 MoA in immuno-oncology
21 Mar 2018, 12:55
4D pharma will present data outlining key aspects of the mode of action of MRx0518 at the Microbiome…
Oncology candidate update
21 Mar 2018, 08:52
4D pharma plc (AIM: DDDD), a pharmaceutical company focusing on the development of live…

BACK TO TOP